Drugs / Dermal fibroblasts
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04483934 | Oct 2014 → Sep 2016 | chronic ulcer of skin, ulcer disease | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dermal fibroblasts | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04483934 ↗ |
| Modality | Cell therapy | “Dermal fibroblasts were isolated from the skin patients, cultured and then transplanted back to the wound.” NCT04483934 ↗ |
| Route | Other | “using injection of autologous dermal fibroblasts in the wound” NCT04483934 ↗ |